Fushiming Capsule Attenuates Diabetic Rat Retina Damage via Antioxidation and Anti-Inflammation

Figure 8

FSM downregulates the detrimental accumulation of AGEs, MDA, and NO after 42-d treatment (72 d of total duration of diabetes). (a) The serum level of AGEs; (b) the serum level of MDA; (c) the serum level of NO. Values are presented as mean ± SD, n=8. p < 0.05, p < 0.01: untreated diabetic model group, CaD group, FSM high-dose, FSM medium-dose, and FSM low-dose group vs normal group; ^#p < 0.05, ^##p < 0.01: CaD group, FSM high-dose, FSM medium-dose, and FSM low-dose group vs untreated diabetic model group.

(a)

(b)

(c)